Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

Filters

My NCBI Filters

Text availability

Article attribute

Article type

Publication date

Search Results

229 results

Filters applied: . Clear all
Results are displayed in a computed author sort order. The Results By Year timeline is not available.
Page 1
Efficacy and safety of subcutaneous anti-tumor necrosis factor-alpha agents, etanercept and adalimumab, in elderly patients affected by psoriasis and psoriatic arthritis: an observational long-term study.
Esposito M, Giunta A, Mazzotta A, Zangrilli A, Babino G, Bavetta M, Perricone R, Chimenti S, Chimenti MS. Esposito M, et al. Among authors: perricone r. Dermatology. 2012;225(4):312-9. doi: 10.1159/000345623. Epub 2012 Dec 28. Dermatology. 2012. PMID: 23295383 Free article.
Elderly psoriatic arthritis patients on TNF-α blockers: results of an Italian multicenter study on minimal disease activity and drug discontinuation rate.
Costa L, Lubrano E, Ramonda R, Chimenti MS, Vezzù M, Perrotta FM, Del Puente A, Peluso R, Bottiglieri P, Lorenzin M, Sunzini F, Darda MA, Fiocco U, Perricone R, Punzi L, Scarpa R, Caso F. Costa L, et al. Among authors: perricone r. Clin Rheumatol. 2017 Aug;36(8):1797-1802. doi: 10.1007/s10067-017-3697-3. Epub 2017 Jun 7. Clin Rheumatol. 2017. PMID: 28589323
Effectiveness and safety of ustekinumab in naïve or TNF-inhibitors failure psoriatic arthritis patients: a 24-month prospective multicentric study.
Chimenti MS, Ortolan A, Lorenzin M, Triggianese P, Talamonti M, Costa L, Caso F, Favero M, Teoli M, Galluzzo M, Scarpa R, Punzi L, Perricone R, Ramonda R. Chimenti MS, et al. Among authors: perricone r. Clin Rheumatol. 2018 Feb;37(2):397-405. doi: 10.1007/s10067-017-3953-6. Epub 2018 Jan 4. Clin Rheumatol. 2018. PMID: 29302829
Retention rates and identification of factors associated with anti-TNFα, anti-IL17, and anti-IL12/23R agents discontinuation in psoriatic arthritis patients: results from a real-world clinical setting.
Navarini L, Costa L, Tasso M, Chimenti MS, Currado D, Fonti GL, Ciccozzi M, Margiotta DPE, Benigno C, De Martino E, Perricone R, Afeltra A, Scarpa R, Caso F. Navarini L, et al. Among authors: perricone r. Clin Rheumatol. 2020 Sep;39(9):2663-2670. doi: 10.1007/s10067-020-05027-1. Epub 2020 Mar 18. Clin Rheumatol. 2020. PMID: 32189149
Efficacy and safety of baricitinib in 446 patients with rheumatoid arthritis: a real-life multicentre study.
Guidelli GM, Viapiana O, Luciano N, De Santis M, Boffini N, Quartuccio L, Birra D, Conticini E, Chimenti MS, Bazzani C, Bruschi E, Riva M, Canziani LM, Bianchi G, Pozzi MR, Limonta M, Gorla R, Perricone R, Frediani B, Moscato P, De Vita S, Dagna L, Rossini M, Selmi C. Guidelli GM, et al. Among authors: perricone r. Clin Exp Rheumatol. 2021 Jul-Aug;39(4):868-873. doi: 10.55563/clinexprheumatol/pudtpo. Epub 2020 Dec 18. Clin Exp Rheumatol. 2021. PMID: 33338001
Duration of clinical remission and low disease activity impacts on quality of life and its domains in psoriatic arthritis patients: results from an Italian multicentre study.
Navarini L, Currado D, Caso F, Costa L, Chimenti MS, D'Antonio A, Tasso M, Salvato M, Laudisio A, Di Donato S, Biaggi A, Marino A, Picchianti Diamanti A, Palmisano E, Ruscitti P, Berardicurti O, Germinario S, Cipriani P, Perricone R, Laganà B, Scarpa R, Afeltra A, Giacomelli R. Navarini L, et al. Among authors: perricone r. Clin Exp Rheumatol. 2022 Jul;40(7):1285-1292. doi: 10.55563/clinexprheumatol/tgdj0p. Epub 2021 Oct 19. Clin Exp Rheumatol. 2022. PMID: 34665697
229 results